Souhaitez-vous accéder aux communiqués récents ?

Labviva, the leading AI procurement platform for life sciences, today announced the close of its $25 million Series B.

CITRYLL RAISES EUR 85 MILLION SERIES B TO ADVANCE NOVEL NET-TARGETING THERAPY FOR IMMUNE-MEDIATED INFLAMMATORY DISORDERS Financing co-led by Johnson & Johnson Innovation – JJDC, Inc., Forbion and...

SAN FRANCISCO, Nov. 11, 2024 (GLOBE NEWSWIRE) -- 11x, the leader in AI-powered digital workers for revenue teams, today announced the closing of a $50 million Series B funding round led by...

Gilde Healthcare Leads Series B Extension, Joining Premier Syndicate of Leading Life Science Investors Funding Supports Registrational Phase 3 TANGENT Trial of Emactuzumab, a Best-in-Class CSF-1...

Fable Raises $25m in Series B Funding to Protect Accessibility in the Age of AI

Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases Oversubscribed financing led by Sofinnova Partners in collaboration with Gilde...

Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases Oversubscribed financing led by Sofinnova Partners in collaboration with Gilde...

TORONTO, June 18, 2024 (GLOBE NEWSWIRE) -- Waabi, a company pioneering generative AI for the physical world, today announced it has raised $200 million (USD) in an oversubscribed Series B round, led...

-- Proceeds support advancing Attovia’s lead programs through initial clinical readouts, expanding its pipeline, and ongoing development of the ATTOBODY™ platform -- Financing led by Goldman Sachs...

Fieldguide Raises $30M Series B, Launches AI Platform to Solve CPA Talent Shortage: Expanding market reach and product capabilities in 2024.